












































Routine HIV screening in health
care settings, including prisons and jails,
is recommended by the US Centers for
Disease Control and Prevention to
enhance the detection of HIV infection.1,2
A centerpiece of this strategy is opt-out
HIV screening whereby patients are
informed that testing will be conducted
unless they decline the test. Although
incarceration is considered an opportunity
to detect HIV and initiate or restart HIV
care,3–6 there are few data describing the
performance of an opt-out testing policy in
prisons, where HIV prevalence is several-
fold that found in the general population.3
In November 2008, the North
Carolina Department of Public Safety
(NCDPS) Division of Adult Correction
changed its HIV screening policy for
incoming inmates from opt-in to opt-out
testing. At the time of the policy change,
we were conducting a HIV seropreva-
lence study among incoming prisoners.7
The co-occurrence of the change in
policy and our seroprevalence study
provided a natural experiment to assess
the impact of the testing policy on HIV
case detection of both newly diagnosed
and previously diagnosed cases.
METHODS
This study was approved by the
University of North Carolina Institutional
Review Board, the NCDPS Human Sub-
jects Review Committee, and the Office
of Human Research Protections at the US
Department of Health and Human
Services (DHHS).
The parent study was supported by the National
Institute of Mental Health, National Institutes of
Health (NIH), Grant R01 MH079720-01A1; this
analysis was supported by NIH Grant R01
AI116384 and by the University of North
Carolina at Chapel Hill Center for AIDS Research
(CFAR), an NIH funded program, P30 AI 50410.
D.A.W. was supported in part by K24
DA037101, and C.E.G. was supported in part
by K24 HD069204. The remaining authors have
no funding or conflicts of interest to disclose.
and of missing HIV status data (ie, those
missing a Prison HIV Test, Study HIV
Test, and with no record of a state diag-
nosis) using, respectively, multivariable
regression models and both multiple impu-
tation and a series of deterministic sensi-
tivity analyses. The primary data analyses
were conducted using SAS version 9.2
(Cary, NC). A full description of sensitiv-
ity analyses methods are available by
request to the corresponding author.
RESULTS
During the study period, 23,373
sentenced prisoners (10,756 during opt-
in and 12,617 during opt-out) entered
the NCDPS (Fig. 1). A Study HIV Test
was available for 94.7% (n = 22,134) of
all incoming prisoners (opt-in: 96.0%,
opt-out: 93.6%, P , 0.001). Of the
94.7%, 320 were HIV seropositive.
Among the 5.3% (n = 1239) of inmates
who were missing a Study HIV Test,7
48 cases were identified by the Prison
Test and state record (n = 36) or by state
record alone (n = 12). Of the 368 total
HIV cases, there were 177 during opt-in
and 191 during opt-out, resulting in
respective HIV prevalence estimates of
1.7% (95% CI: 1.5 to 1.9) and 1.5%
(95% CI: 1.3 to 1.8); these estimates were
not statistically different (P = 0.34).
HIV Screening and Probability
of Case Detection Under Opt-In
and Opt-Out Conditions
The proportion of entering in-
mates receiving an HIV test during
opt-in, 58.8%, and during opt-out test-
ing, 95.2%, differed significantly (P ,
0.001). The estimated probability of
detecting a case among those without
a previous diagnosis was 0.2 (2/10) and
0.4 (4/10), P = 0.63, during opt-in and
opt-out testing, respectively. Given the
low number of HIV cases (n = 20) that
entered prison without record of a pre-
vious diagnosis, the remaining analyses
examined case detection regardless of
previous diagnosis. The proportion of
cases detected by the prison system,
irrespective of previous diagnosis, was
0.76 (134/177) during opt-in and 0.90
(172/191) during opt-out, resulting in an
estimated RD of 0.14 (95% CI: 0.07 to
0.22), based on analyses of records without
missing HIV status data. Standardizing
the number of HIV cases during the study
period to account for 25,000 annual
entrants [25,000 annual prison entrants ·
(368 HIV cases/22,892 prison entrants)],
results in an estimated 402 HIV-positive
annual entrants. With 402 HIV-positive
inmates entering the prison system annu-
ally, opt-out testing would have detected
56 (= 402 · 0.14) additional HIV cases as
compared with opt-in.
Adjusting for confounding and for
missing HIV status data had only a modest
influence on our findings, resulting in
between 53 and 80 additional annual HIV
cases detected under opt-out vs. opt-in.
DISCUSSION
The adoption of opt-out HIV testing
led to a sharp and large increase in the
proportion of prisoners tested for HIV
infection in this state prison system from
nearly 60% to more than 95%. In addition,
under opt-out testing, a greater proportion
of HIV-infected individuals entering prison
was tested compared with under opt-in.
The dramatic increase in uptake of HIV
testing with the adoption of opt-out testing
mirrors that reported in the Washington
state prison system8 and is consistent with
observations from sexually transmitted
infection clinics.9–11
Expanded HIV testing of individu-
als at risk for HIV infection, as was
observed with the shift to opt-out, is
a linchpin in the strategy to contain the
spread of the virus.1 We found that under
opt-out testing, the probability of HIV case
detection was approximately 15% higher
than for opt-in testing. With an annual
intake population of 25,000, opt-out would
yield approximately 60 more cases than
would have been discovered with opt-in
testing. However, rather than representing
new cases, the vast majority of HIV cases
identified by the prison system were
already known to the DHHS.7
Although the primary intent of opt-
out testing of prisoners is to reveal pre-
viously undetected cases of HIV, the
adoption of an opt-out policy in this
correctional setting produced a low yield
as most of those detected with HIV were
already known to the state. However, if
the intent is to identify people in need for
HIV care, then opt-out testing does pro-
vide benefit over opt-in testing. For those
who test positive and entered aware of
their HIV status, testing has an important
Study Population and Setting
All sentenced individuals entering 
the NCDPS between June 2008 and 
April 2009 were studied. Entering in-
mates underwent HIV screening within 
2 weeks of prison entry. Before the 
change in policy (June 1 to October 
31, 2008), HIV testing was offered 
under opt-in conditions, wherein a prison 
nurse conducted pretest counseling and 
asked inmates if they wanted to be 
tested. After the policy change (Novem-
ber 1, 2008 to April 15, 2009), HIV 
testing was provided in an opt-out 
manner, in which inmates were 
informed that they would be tested for 
HIV unless they declined testing.
Data Sources and Linkage
To determine whether HIV cases 
were detected or missed by prison 
system screening, we linked individual-
level records from the prison system’s 
HIV test (referred to hereafter as the 
Prison Test) and the HIV test we con-
ducted to assess seroprevalence (referred 
to hereafter as the Study Test), which 
used excess blood from mandatory 
syphilis testing.7 We also determined 
whether incoming prisoners had been 
previously diagnosed with HIV, docu-
mented by NC DHHS record.
These testing and diagnosis data 
were integrated into a single database of 
all sentenced prisoners during the study 
period. Before populating the database 
with results from the Study Test, pris-
oner identifiers were removed.
Statistical Considerations
The primary goal of the analysis 
was to estimate the difference across 
opt-in and opt-out testing policies in the 
annual number of cases detected by the 
prison system.
Accordingly, we estimated the risk 
difference (RD) in case detection across 




















estimated RD by an estimate of the annual
number of HIV cases entering the prison 
system to estimate the annual difference in 
the number of cases detected under opt-out 
as compared with opt-in testing.
We also assessed the potential 
influence on our results of confounding
role in linking inmates into prison HIV
care. Similarly, if tested individuals
included those among the small minority
in the state who were diagnosed previously
but were unaware of their status or had
never engaged in care previously,12 testing
would also prompt entry into care. The
importance of identifying out-of-care HIV-
positive individuals was highlighted in
a systematic review of studies suggesting
that once HIV-positive inmates are linked
into prison HIV care, their rates of
retention are much higher during incar-
ceration (76%) than in the community
(30%–40%).13 With these benefits
in mind, it is important that opt-out
testing, which in prison is susceptible to
being used without inmates’ full knowl-
edge,14,15 be conducted in an informed
and noncoercive manner.
This study has limitations.
Although the Study Test was not avail-
able for 5% of inmates, we conducted
several sensitivity analyses, all of which
suggested that missing data had little
influence on our results. Additionally,
for previously detected cases, the venue
at which they first tested positive and
whether they received their results were
not known, and we could not determine
the influence of knowing one’s own
serostatus on their testing decision; it is
possible that people who knew them-
selves to be positive were more likely to
decline the test under opt-in compared
with opt-out, but still sought care. Sim-
ilarly, data were not available on prison-
ers’ linkage to and engagement in care
after a positive HIV test during intake.
Finally, the finding of few undetected
HIV cases may not be generalizable to
other correctional systems.16
In summary, the switch from opt-
in to opt-out testing greatly increased the
proportion of inmates tested for HIV,
including those with HIV infection.
Although research is needed to under-
stand the effects of opt-out HIV testing
in other prison settings, our findings
indicate that expanded HIV testing of
prisoners may not lead to detection of
large numbers of newly identified cases
but can potentially be a tool for enlisting
previously diagnosed inmates into care
during their incarceration.
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